The emerging approach of this peptide represents a significant advance in the management of diabetes mellitus type 2. Distinct from existing drugs, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatide-peptide185727.timeblog.net/77924822/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment